Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by tylerreddickon Aug 29, 2023 8:35am
165 Views
Post# 35609433

RE:RE:RE:RE:Analysts will be busy tonight....

RE:RE:RE:RE:Analysts will be busy tonight....Not too difficult.
280 million PIPE shares gets 8.87% of AmalCo, so at $2.15/share that would be $602 million.
So the market cap of AmalCo would be $602/0.0887, or about $6.8 billion.
Add $2.9 billion of debt for a total EV of $9.7.
Divide by 185,000 boed, and you get $52,400/boed.
Simple math.

But once again, that just highlghts how over-valued Strathcona was with the original deal, and why PIPE's share price cratered to compensate for that bs.
<< Previous
Bullboard Posts
Next >>